Neuraptive Therapeutics

Neuraptive Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutics and medical products for peripheral nerve injuries (PNI). Founded in 2016 and headquartered in Louisville, Colorado, with additional offices in Philadelphia and Lafayette, the company aims to improve patient outcomes following acute nerve injuries and reconstructive surgeries. Its product portfolio includes AxoFuse, a nerve repair system that prevents degeneration and atrophy; AxoTrim, a surgical instrument for nerve preparation; AxoBond, which secures repaired nerves during recovery; and NTX-001, a drug-device product for surgical applications. Neuraptive's products are designed to enhance recovery speed and quality for patients, leveraging advanced microsurgical techniques to address the challenges posed by PNI. The company originated from technology developed at the University of Texas, reflecting its commitment to innovation in the field of nerve repair.